|
The role of ion channels and transporters in B cell function |
1F30AI164803-01A1 |
|
NIAID |
2022 |
|
Interrogating immune signatures in the thoracic duct of patients with multiple sclerosis |
1F31AI167501-01 |
|
NIAID |
2022 |
|
Investigation of enterovirus D68 pathogenesis in the human spinal cord |
1K08AI171177-01 |
|
NIAID |
2022 |
|
Targeting OCA-B in multiple sclerosis |
1R01AI162929-01A1 |
|
NIAID |
2022 |
|
CAR-T cell treatment of CNS Autoimmunity |
1R01AI165771-01A1 |
|
NIAID |
2022 |
|
Tissue-Specific Mechanisms of Regulatory T Cells in the CNS during Autoimmune Encephalomyelitis |
1R01AI168063-01 |
|
NIAID |
2022 |
|
Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course |
1R01AI169070-01A1 |
|
NIAID |
2022 |
|
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots |
1R01AI169686-01 |
|
NIAID |
2022 |
|
Defining how TCR strength of signal modulates Treg function |
1R01AI169835-01A1 |
|
NIAID |
2022 |
|
Novel mouse models to dissect the role of genetics, sex, and environment in heterogeneous outcomes in CNS autoimmune disease |
1R01AI172166-01 |
|
NIAID |
2022 |